The parent company, Southern Implants (Pty) Ltd, developes and manufactures dental implants and associated prosthetic devices. Southern Implants has been one of the pioneers in this field and has contributed extensively to the enhancements with respect to osseo-integration of implant devices, surgical techniques, patient education and options of treatment. Southern Implants is not only the leading dental implant company in South Africa, but is a significant role player in the USA, Europe and Australasia.
The success with implementation of the highest quality standards enabled the establishment of a plant for the processing of bovine pericardium and the development of a mitral heart valve utilizing this material. Glycar (Pty) Ltd, an associated company was established to manufacture and develop the applications for cross-linked collagenous membranes.
The development of orthopaedic implant devices capitalized on the extensive experience of the company with respect to precision machining and processing of implantable materials such as titanium, as well as knowledge of surface treatments for enhanced integration. This prompted the formation of Southern Medical (Pty) Ltd, a company dedicated to the highest standards of manufacture and research and development of orthopaedic and neurosurgical implantable devices.
The Southern Group of Companies is furthermore comprised of:
Southern Cryoscience, a non-profit company for the high quality harvesting and cryopreservation of homograft heart valves. This takes place in a state of the art, Class 100 facility, specifically erected for this purpose.
Southern ENT (Pty) Ltd is the Southern company dedicated to the development of products for the ENT field. This company is also the proud distributors of the Nucleus Cochlear implants as well as the Cochlear Bone Anchored Hearing (BAHA) systems for the hearing impaired.
Medika SA (Pty) Ltd is the Southern Group company dedicated to the research of, and development of woundcare products.
The Southern Group of Companies is firmly committed to ensuring excellence in medical implantation devices, and at affordable prices. The group's employees count in excess of 180 staff, which includes a strong Research and Development Department. The group is developing numerous devices which will ensure that it remains the leading biotechnology group in South Africa.